Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Novavax Boosts Vaccines With $38M Public Offering

March 22, 2006

By Jennifer Boggs

Novavax Boosts Vaccines With $38M Public Offering

March 22, 2006

By Jennifer Boggs

MGI Starts Aquavan Phase III Program For Small Surgeries

March 22, 2006

By Jennifer Boggs

PTC, Schering Sign $200M Preclinical HCV Partnership

March 21, 2006

By Jennifer Boggs

PTC, Schering Sign $200M Preclinical HCV Partnership

March 21, 2006

By Jennifer Boggs

Restructuring Gets Stressgen C$9M For HspE7 Development

March 20, 2006

By Jennifer Boggs

Restructuring Gets Stressgen C$9M For HspE7 Development

March 20, 2006

By Jennifer Boggs

Chiron Pulls Measles Vaccine Off Developing World Market

March 17, 2006

By Jennifer Boggs

Chiron Pulls Measles Vaccine Off Developing World Market

March 17, 2006

By Jennifer Boggs

GenVec Gets Access To $30M For Expanded TNFerade Trial

March 16, 2006

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...